Table 1—

Subject characteristics

Asthmatic subjectsRemission subjects
Subjects n1010
Age yrs22.5±0.5 (19–25)20.6±0.6 (19–24)
Sex M:F7:310:0
FEV1 L·min−190±3 (80–106)91±4 (63–107)
PD20 MCh µmol0.4±0.3 (0.1–2.8)2.3±1.1 (0.1–9.9)
PD20 AMP µmol5.3±2.3 (0.6–27.3)9.8±2.6 (1.0–22.2)
  • Age and forced expiratory volume in one second (FEV1) are presented as mean±sem (range) and the provocative dose causing a 20% fall in the FEV1 (PD20) as median±sem (range)

  • MCh: methacholine

  • AMP: adenosine monophosphate

  • M: male

  • F: female